Supernus Pharmaceuticals (SUPN) Q2 2016 Earnings

3MayConfirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
0.02
0.06
0.1
0.14

Details

Expected EPS
0.09
Actual EPS
0.08
Surprise EPS
-0.01
Surprise Percent
+11.11%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.08 per share for Q2 2016.

0 Comments

Share your thoughts